APSR2026-458

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-039
P47
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220570-46904-APSR-458_440320.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Sonia Ellomalay * Hospital Tuanku Ja'afar Seremban Respiratory Unit , Department of Internal Medicine Seremban Malaysia
Anez Aslan - Hospital Tuanku Ja'afar Seremban Respiratory Unit , Department of Internal Medicine Seremban Malaysia
Han loong Tan - Hospital Tuanku Ja'afar Seremban Respiratory Unit , Department of Internal Medicine Seremban Malaysia
Raymund Dass Maria Dass - Hospital Tuanku Ja'afar Seremban Respiratory Unit , Department of Internal Medicine Seremban Malaysia
Shobhana Sivandan - Hospital Tuanku Ja'afar Seremban Radiology Department Seremban Malaysia
Zamzurina Abu Bakar - Institut Perubatan Respiratori Respiratory Unit Kuala Lumpur Malaysia
 
 
 
 
 
 
 
 
 
Presenting Author Details
Sonia
Ellomalay
sonia_ellomalay@yahoo.com
+60146443540
Under 30
Malaysia
Case Report
Macrolide-Susceptible but Difficult to Treat: Clinical and Therapeutic Challenges in Mycobacterium abscessus pulmonary disease
Maximum 25 words
Abstract Content
 
 
 
 
Non-Tuberculous Mycobacterium (NTM) pulmonary disease with Mycobacterium Abscessus is one of the common opportunistic infections particularly among patients with underlying structural lung disease. As a rapidly growing mycobacterium, it possesses broad intrinsic antimicrobial resistance resulting in limited effective treatment options.
We report two patients with underlying structural lung disease who had Mycobacterium Abscessus pulmonary disease. Both patients presented with prolonged cough and copious sputum production. Initial chest radiographs showed cavitation and consolidations while CT Thorax demonstrated cavitating lung disease with bronchiectasis. Persistent sputum positivity for acid-fast bacilli with negative Genexpert/RIF assays. Consequently, standard anti-tuberculosis therapy was commenced, however no clinical or microbiological improvement. Subsequent cultures identified Mycobacterium abscessus subsp. Abscessus and a decision to treat was made. Despite genotypic macrolide susceptibility and absence of inducible erm (41) mutation, both cases demonstrated resistance to multiple companion drugs, limiting the construction of an effective multidrug regimen. Antibiotic selection was guided by minimum inhibitory concentration (MICs) but treatment was still limited by hepatotoxicity, gastrointestinal intolerance and hypersensitivity reactions. The first patient received intensive phase of intravenous amikacin, oral clarithromycin, ciprofloxacin, clofazimine for 2 months followed by continuation phase with oral clofazimine, clarithromycin and ciprofloxacin which was discontinued due to adverse effects. A strategy of watchful waiting was adopted, and he remains clinically stable despite limited radiological improvement. The second patient received shortened intensive phase consisting of intravenous amikacin, oral clarithromycin, ciprofloxacin, clofazimine and bactrim due to intolerance, followed by re-initiation of treatment with nebulized amikacin, oral clarithromycin, ciprofloxacin and clofazimine for one year. He achieves symptomatic improvement and sustained culture negativity.
This case series highlights the complexity of managing Mycobacterium abscessus pulmonary disease with multiple companion drug resistance. Our cases demonstrates that macrolide susceptibility alone does not guarantee treatment success hence individualized strategies are often required.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Mycobacterium abscessus , Minimum Inhibitory Concentration, Macrolide Susceptibility
maximum 3 keywords and no abbreviations, separated by commas
 
294